Melatonin acts through MT1/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats

• Published in: American journal of physiology: endocrinology and metabolism 2013-07, Vol.305 (2), p.E230-E242
• Main Authors: Faria, Juliana A, Kinote, Andrezza, Ignacio-Souza, Letícia M, de Araújo, Thiago M, Razolli, Daniela S, Doneda, Diego L, Paschoal, Lívia B, Lellis-Santos, Camilo, Bertolini, Gisele L, Velloso, Lício A, Bordin, Silvana, Anhê, Gabriel F
• Format: Article
• Language: English
• Subjects: Animals; Antioxidants - pharmacology; Blotting, Western; Fluorescent Antibody Technique; Gluconeogenesis - drug effects; Glucose; Glucose Tolerance Test; Homeostasis; Hypothalamus - drug effects; Hypothalamus - metabolism; Injections, Intraventricular; Insulin resistance; Liver - drug effects; Liver - metabolism; Male; Melatonin; Melatonin - pharmacology; Obesity; Oncogene Protein v-akt - metabolism; Phosphatidylinositol 3-Kinases - metabolism; Phosphorylation; Pyruvic Acid - metabolism; Rats; Rats, Wistar; Receptor, Melatonin, MT1 - drug effects; Receptor, Melatonin, MT2 - drug effects; Receptors, Muscarinic - drug effects
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00094.2013

Melatonin can contribute to glucose homeostasis either by decreasing gluconeogenesis or by counteracting insulin resistance in distinct models of obesity. However, the precise mechanism through which melatonin controls glucose homeostasis is not completely understood. Male Wistar rats were administered an intracerebroventricular (icv) injection of melatonin and one of following: an icv injection of a phosphatidylinositol 3-kinase (PI3K) inhibitor, an icv injection of a melatonin receptor (MT) antagonist, or an intraperitoneal (ip) injection of a muscarinic receptor antagonist. Anesthetized rats were subjected to pyruvate tolerance test to estimate in vivo glucose clearance after pyruvate load and in situ liver perfusion to assess hepatic gluconeogenesis. The hypothalamus was removed to determine Akt phosphorylation. Melatonin injections in the central nervous system suppressed hepatic gluconeogenesis and increased hypothalamic Akt phosphorylation. These effects of melatonin were suppressed either by icv injections of PI3K inhibitors and MT antagonists and by ip injection of a muscarinic receptor antagonist. We conclude that melatonin activates hypothalamus-liver communication that may contribute to circadian adjustments of gluconeogenesis. These data further suggest a physiopathological relationship between the circadian disruptions in metabolism and reduced levels of melatonin found in type 2 diabetes patients.